Can a new formulation of opiate agonist treatment alter stigma?: Place, time and things in the experience of extended-release buprenorphine depot.  Treloar C, Lancaster K, Gendera S, Rhodes T, Shahbazi J, Byrne M, Degenhardt L, Farrell M. …

Individual, interpersonal, and neighborhood measures associated with opioid use stigma: Evidence from a nationally representative survey.  Lin Q, Kolak M, Watts B, Anselin L, Pollack H, Schneider J, Taylor B.  Soc Sci Med. 2022 Jul;305:1…

Language Matters: Is This a Drug Overdose or Drug Poisoning Crisis? In public policy, language matters. In drug policy, language has always been divisive. Words from “dealer” to “addict” have been used to marginalise, incarcerate, and strip three-d…

Course and Correlates of Stigma in Patients on Opioid Agonist Treatment: A Prospective Study from an Outpatient Treatment Program in India.  Ghosh A, Roub F, Pillai RR, Mahintamani T, Basu D, Subodh BN, Mattoo SK.  Indian J Psychol Med…

Factors influencing medical students' attitudes towards substance use during pregnancy. Richelle L, Dramaix-Wilmet M, Roland M, Kacenelenbogen N.  BMC Med Educ. 2022 May 2;22(1):335. doi: 10.1186/s12909-022-03394-8. PMID: 35501752; PMCID: PMC…

Applicability of a national strategy for patient-oriented research to people who use(d) substances: a Canadian experience.  Pauly B, Sullivan G, Inglis D, Cameron F, Phillips J, Rosen C, Bullock B, Cartwright J, Hainstock T, Trytten C, Urbanos…